Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing

被引:193
作者
Hershfield, M. S. [1 ,2 ]
Callaghan, J. T. [3 ,4 ,5 ]
Tassaneeyakul, W. [6 ]
Mushiroda, T. [7 ]
Thorn, C. F. [8 ]
Klein, T. E. [8 ]
Lee, M. T. M. [9 ,10 ,11 ]
机构
[1] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA
[2] Duke Univ, Sch Med, Dept Biochem, Durham, NC USA
[3] Dept Vet Affairs Med Ctr, ACOS Res, Indianapolis, IN USA
[4] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA
[5] Indiana Univ Sch Med, Dept Pharmacol Toxicol, Indianapolis, IN USA
[6] Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen, Thailand
[7] RIKEN, Ctr Genom Med, Lab Pharmacogenet, Yokohama, Kanagawa, Japan
[8] Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA
[9] Acad Sinica, Inst Biomed Sci, Natl Ctr Genome Med, Taipei, Taiwan
[10] China Med Univ, Sch Chinese Med, Taichung, Taiwan
[11] RIKEN, Ctr Genom Med, Lab Int Alliance, Yokohama, Kanagawa, Japan
基金
美国国家卫生研究院;
关键词
STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; GENOME-WIDE ASSOCIATION; HLA-B; RISK-FACTOR; GOUT; HEALTH; HYPERSENSITIVITY; PREVALENCE; HLA-B-ASTERISK-5801;
D O I
10.1038/clpt.2012.209
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Allopurinol is the most commonly used drug for the treatment of hyperuricemia and gout. However, allopurinol is also one of the most common causes of severe cutaneous adverse reactions (SCARs), which include drug hypersensitivity syndrome, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A variant allele of the human leukocyte antigen (HLA)-B, HLA-B*58:01, associates strongly with allopurinol-induced SCAR. We have summarized the evidence from the published literature and developed peer-reviewed guidelines for allopurinol use based on HLA-B genotype.
引用
收藏
页码:153 / 158
页数:6
相关论文
共 40 条
[1]   The DRESS Syndrome: A Literature Review [J].
Cacoub, Patrice ;
Musette, Philippe ;
Descamps, Vincent ;
Meyer, Olivier ;
Speirs, Chris ;
Finzi, Laetitia ;
Roujeau, Jean Claude .
AMERICAN JOURNAL OF MEDICINE, 2011, 124 (07) :588-597
[2]  
Chao Jeannie, 2009, Curr Rheumatol Rep, V11, P135
[3]   Safety and Efficacy of Febuxostat Treatment in Subjects with Gout and Severe Allopurinol Adverse Reactions [J].
Chohan, Saima .
JOURNAL OF RHEUMATOLOGY, 2011, 38 (09) :1957-1959
[4]  
Chuang SY, 2011, ASIA PAC J CLIN NUTR, V20, P301
[5]   Human leukocyte antigens and drug hypersensitivity [J].
Chung, Wen-Hung ;
Hung, Shuen-Lu ;
Chen, Yuan-Tsong .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 7 (04) :317-323
[6]   A marker for Stevens-Johnson syndrome [J].
Chung, WH ;
Hung, SI ;
Hong, HS ;
Hsih, MS ;
Yang, LC ;
Ho, HC ;
Wu, JY ;
Chen, YT .
NATURE, 2004, 428 (6982) :486-486
[7]   Allopurinol dosing in renal impairment: Walking the tightrope between adequate urate lowering and adverse events [J].
Dalbeth, Nicola ;
Stamp, Lisa .
SEMINARS IN DIALYSIS, 2007, 20 (05) :391-395
[8]   Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe [J].
Genin, Emmanuelle ;
Schumacher, Martin ;
Roujeau, Jean-Claude ;
Naldi, Luigi ;
Liss, Yvonne ;
Kazma, Remi ;
Sekula, Peggy ;
Hovnanian, Alain ;
Mockenhaupt, Maja .
ORPHANET JOURNAL OF RARE DISEASES, 2011, 6
[9]   Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel [J].
Halevy, Sitna ;
Ghislain, Pierre-Dominique ;
Mockenhaupt, Maja ;
Fagot, Jean-Paul E. ;
Bavinck, Jan Nico Bouwes ;
Sidoroff, Alexis ;
Naldi, Luigi ;
Dunant, Ariane ;
Viboud, Cecile ;
Roujeau, Jean-Claude .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (01) :25-32
[10]   Gene map of the extended human MHC [J].
Roger Horton ;
Laurens Wilming ;
Vikki Rand ;
Ruth C. Lovering ;
Elspeth A. Bruford ;
Varsha K. Khodiyar ;
Michael J. Lush ;
Sue Povey ;
C. Conover Talbot ;
Mathew W. Wright ;
Hester M. Wain ;
John Trowsdale ;
Andreas Ziegler ;
Stephan Beck .
Nature Reviews Genetics, 2004, 5 (12) :889-899